We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Janus Henderson Global Life Sciences Equity Class I - Accumulation (GBP)

Sell:126.40p Buy:126.40p Change: 0.20p (0.16%)
Prices as at 9 January 2026
Sell:126.40p
Buy:126.40p
Change: 0.20p (0.16%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 9 January 2026
Sell:126.40p
Buy:126.40p
Change: 0.20p (0.16%)
Prices as at 9 January 2026
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 94.43%
UK Equities 4.30%
Alternative Trading Strategies 1.24%
Other 0.04%

Top 10 holdings

Stock name % Weight Country Sector
1 ELI LILLY AND COMPANY 9.51% USA Pharmaceuticals & Biotechnology
2 JOHNSON & JOHNSON 5.35% USA Pharmaceuticals & Biotechnology
3 ASTRAZENECA 4.30% GBR Pharmaceuticals & Biotechnology
4 UNITEDHEALTH GROUP INCORPORATED 3.39% USA Health Care Providers
5 ABBVIE 3.28% USA Pharmaceuticals & Biotechnology
6 ARGENX SE 2.86% NLD Pharmaceuticals & Biotechnology
7 ABBOTT LABORATORIES 2.74% USA Medical Equipment & Services
8 BOSTON SCIENTIFIC CORPORATION 2.43% USA Medical Equipment & Services
9 SANOFI 2.39% FRA Pharmaceuticals & Biotechnology
10 THERMO FISHER SCIENTIFIC 2.34% USA Medical Equipment & Services

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account